52 phenotypes from 6 alleles in 4 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
C9orf72em1Eggn/C9orf72em1Eggn involves: C57BL/6	decreased hematocrit	J:240357
	enlarged cervical lymph nodes	J:240357
	enlarged spleen	J:240357
	increased anti-double stranded DNA antibody level	J:240357
	premature death	J:240357
C9orf72em5Lutzy/C9orf72em5Lutzy C57BL/6-C9orf72em5Lutzy	abnormal macrophage physiology	J:101977
	abnormal microglial cell physiology	J:101977
	abnormal spinal cord grey matter morphology	J:101977
	abnormal spinal cord white matter morphology	J:101977
	normal behavior/neurological phenotype	J:101977
	enlarged lymph nodes	J:101977
	enlarged spleen	J:101977
	lysosomal protein accumulation	J:101977
	normal nervous system phenotype	J:101977
C9orf72tm1.1(KOMP)Mbp/C9orf72tm1.1(KOMP)Mbp C57BL/6N-C9orf72tm1.1(KOMP)Mbp/Ucd	abnormal spleen morphology	J:211773
	abnormal vertebral arch morphology	J:211773
	decreased total body fat amount	J:211773
	enlarged lymph nodes	J:211773
	enlarged spleen	J:211773
	increased circulating alkaline phosphatase level	J:211773
	increased lean body mass	J:211773
	increased spleen weight	J:211773
	small testis	J:211773
C9orf72tm1.1Eggn/C9orf72+ involves: C57BL/6 * C57BL/6N	abnormal circulating interleukin level	J:240357
	cachexia	J:240357
	decreased circulating interleukin-2 level	J:240357
	dermatitis	J:240357
	increased autoantibody level	J:240357
	increased IgG level	J:240357
	increased IgM level	J:240357
	respiratory failure	J:240357
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn involves: C57BL/6 * C57BL/6N	abnormal circulating cytokine level	J:240357
	abnormal lymphocyte morphology	J:240357
	abnormal spleen morphology	J:240357
	brain inflammation	J:240357
	cachexia	J:240357
	decreased erythrocyte cell number	J:240357
	decreased hematocrit	J:240357
	decreased mean corpuscular volume	J:240357
	dermatitis	J:240357
	enlarged liver	J:240357
	enlarged spleen	J:240357
	increased anti-double stranded DNA antibody level	J:240357
	increased autoantibody level	J:240357
	increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:240357
	increased IgG level	J:240357
	increased IgM level	J:240357
	increased leukocyte cell number	J:240357
	increased neutrophil cell number	J:240357
	increased splenocyte number	J:240357
	increased susceptibility to autoimmune disorder	J:240357
	liver inflammation	J:240357
	microcytic anemia	J:240357
	normal nervous system phenotype	J:240357
	premature death	J:240357
	respiratory failure	J:240357
	thrombocytopenia	J:240357
C9orf72tm1Eggn/C9orf72+ involves: C57BL/6 * C57BL/6N	ataxia	J:240357
	cachexia	J:240357
	dermatitis	J:240357
	enlarged liver	J:240357
	respiratory failure	J:240357
C9orf72tm1Eggn/C9orf72tm1Eggn involves: C57BL/6 * C57BL/6N	abnormal circulating cytokine level	J:240357
	abnormal lymphocyte morphology	J:240357
	cachexia	J:240357
	decreased erythrocyte cell number	J:240357
	decreased hematocrit	J:240357
	decreased mean corpuscular volume	J:240357
	dermatitis	J:240357
	enlarged cervical lymph nodes	J:240357
	enlarged liver	J:240357
	enlarged spleen	J:240357
	increased anti-double stranded DNA antibody level	J:240357
	increased leukocyte cell number	J:240357
	increased neutrophil cell number	J:240357
	increased susceptibility to autoimmune disorder	J:240357
	internal hemorrhage	J:240357
	microcytic anemia	J:240357
	premature death	J:240357
	respiratory failure	J:240357
	thrombocytopenia	J:240357
C9orf72tm1Lagi/C9orf72tm1Lagi involves: C57BL/6 * C57BL/6N	abnormal celiac lymph node morphology	J:232242
	abnormal cervical lymph node morphology	J:232242
	abnormal lymph node cell ratio	J:232242
	abnormal social investigation	J:232242
	decreased body weight	J:232242
	decreased hematocrit	J:232242
	decreased hemoglobin content	J:232242
	decreased lymphocyte cell number	J:232242
	enlarged cervical lymph nodes	J:232242
	enlarged spleen	J:232242
	impaired coordination	J:232242
	increased neutrophil cell number	J:232242
	premature death	J:232242